← All indications
Adenomyoepithelioma
A mixed epithelial and myoepithelial neoplasm usually encountered within the breast. It is a multinodular lesion presenting with a bicellular pattern of proliferating epithelial and myoepithelial cells, which are regularly distributed in the glandular structures.
Organizations
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (21)
- Bristol-Myers Squibb
- AstraZeneca
- Plexxikon
- Celldex Therapeutics
- Boehringer Ingelheim
- National Cancer Institute (NCI)
- Brown University
- Canadian Cancer Trials Group
- Cathay General Hospital
- Cancer Research UK
- University of London
- Gynecologic Oncology Group
- NRG Oncology
- Nordic Society for Gynaecologic Oncology
- Rhode Island Hospital
- University of Glasgow
- University of Toronto
- National University of Singapore
- European Organisation for Research and Treatment of Cancer
- ARCAGY-GINECO
- Memorial Sloan-Kettering Cancer Center
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (2)